Literature DB >> 32615329

Poison exons in neurodevelopment and disease.

Gemma L Carvill1, Heather C Mefford2.   

Abstract

Poison exons are naturally occurring, highly conserved alternative exons that contain a premature termination codon. Inclusion of a poison exon in a transcript targets the transcript for nonsense mediated decay, decreasing the amount of protein produced. Poison exons are proposed to play an important role in tissue-specific expression, development and autoregulation of gene expression. Recently, several studies that performed systematic investigations of alternative splicing in the brain have highlighted the abundance of transcripts containing poison exons, some of which are spliced in a cell type-specific manner. Pathogenic variants in or near poison exons that result in aberrant splicing have been identified in several genes including FLNA, SCN1A and SNRPB. Improved understanding of the role of poison exons in development and disease may present opportunities to solve previously undiagnosed disease and to develop therapeutic approaches in the future.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 32615329      PMCID: PMC8042789          DOI: 10.1016/j.gde.2020.05.030

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  20 in total

Review 1.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

2.  Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay.

Authors:  Julie Z Ni; Leslie Grate; John Paul Donohue; Christine Preston; Naomi Nobida; Georgeann O'Brien; Lily Shiue; Tyson A Clark; John E Blume; Manuel Ares
Journal:  Genes Dev       Date:  2007-03-15       Impact factor: 11.361

3.  Systematic discovery of regulated and conserved alternative exons in the mammalian brain reveals NMD modulating chromatin regulators.

Authors:  Qinghong Yan; Sebastien M Weyn-Vanhentenryck; Jie Wu; Steven A Sloan; Ye Zhang; Kenian Chen; Jia Qian Wu; Ben A Barres; Chaolin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-03       Impact factor: 11.205

4.  Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls.

Authors:  Chaolin Zhang; Maria A Frias; Aldo Mele; Matteo Ruggiu; Taesun Eom; Christina B Marney; Huidong Wang; Donny D Licatalosi; John J Fak; Robert B Darnell
Journal:  Science       Date:  2010-06-17       Impact factor: 47.728

5.  Neuronal regulation of pre-mRNA splicing by polypyrimidine tract binding proteins, PTBP1 and PTBP2.

Authors:  Niroshika Keppetipola; Shalini Sharma; Qin Li; Douglas L Black
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-06-02       Impact factor: 8.250

6.  Separable roles for rent1/hUpf1 in altered splicing and decay of nonsense transcripts.

Authors:  Joshua T Mendell; Colette M J ap Rhys; Harry C Dietz
Journal:  Science       Date:  2002-09-12       Impact factor: 47.728

7.  Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements.

Authors:  Liana F Lareau; Maki Inada; Richard E Green; Jordan C Wengrod; Steven E Brenner
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

8.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans.

Authors:  Benjamin P Lewis; Richard E Green; Steven E Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

9.  RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis.

Authors:  Claire M Mooney; Eva M Jimenez-Mateos; Tobias Engel; Catherine Mooney; Mairead Diviney; Morten T Venø; Jørgen Kjems; Michael A Farrell; Donncha F O'Brien; Norman Delanty; David C Henshall
Journal:  Sci Rep       Date:  2017-01-27       Impact factor: 4.379

10.  NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure.

Authors:  Taesun Eom; Chaolin Zhang; Huidong Wang; Kenneth Lay; John Fak; Jeffrey L Noebels; Robert B Darnell
Journal:  Elife       Date:  2013-01-22       Impact factor: 8.140

View more
  10 in total

1.  Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases.

Authors:  Chunhong Chen; Fang Fang; Xu Wang; Junlan Lv; Xiaohui Wang; Hong Jin
Journal:  Front Mol Neurosci       Date:  2022-04-28       Impact factor: 5.639

2.  Unique Ataxia-Oculomotor Apraxia 2 (AOA2) in Israel with Novel Variants, Atypical Late Presentation, and Possible Identification of a Poison Exon.

Authors:  Vardiella Meiner; Alexander Lossos; Hagit Baris Feldman; Penina Ponger; Alina Kurolap; Israela Lerer; Judith Dagan; Chofit Chai Gadot; Adi Mory; Yael Wilnai; Nino Oniashvili; Nir Giladi; Tanya Gurevich
Journal:  J Mol Neurosci       Date:  2022-06-08       Impact factor: 2.866

3.  Nonsense-mediated decay is highly stable across individuals and tissues.

Authors:  Nicole A Teran; Daniel C Nachun; Tiffany Eulalio; Nicole M Ferraro; Craig Smail; Manuel A Rivas; Stephen B Montgomery
Journal:  Am J Hum Genet       Date:  2021-07-02       Impact factor: 11.025

4.  A spotter's guide to SNPtic exons: The common splice variants underlying some SNP-phenotype correlations.

Authors:  Niall Patrick Keegan; Sue Fletcher
Journal:  Mol Genet Genomic Med       Date:  2021-10-28       Impact factor: 2.183

5.  Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.

Authors:  Niall P Keegan; Steve D Wilton; Sue Fletcher
Journal:  Front Genet       Date:  2022-01-24       Impact factor: 4.772

6.  Molecular and genetic dissection of recursive splicing.

Authors:  Brian Joseph; Chaz Scala; Shu Kondo; Eric C Lai
Journal:  Life Sci Alliance       Date:  2021-11-10

7.  Genome sequencing reveals novel noncoding variants in PLA2G6 and LMNB1 causing progressive neurologic disease.

Authors:  Nicholas Borja; Stephanie Bivona; Lé Shon Peart; Brittany Johnson; Joanna Gonzalez; Deborah Barbouth; Henry Moore; Shengru Guo; Guney Bademci; Mustafa Tekin
Journal:  Mol Genet Genomic Med       Date:  2022-03-05       Impact factor: 2.183

Review 8.  GENE TARGET: A framework for evaluating Mendelian neurodevelopmental disorders for gene therapy.

Authors:  Maya Chopra; Meera E Modi; Kira A Dies; Nancy L Chamberlin; Elizabeth D Buttermore; Stephanie Jo Brewster; Lisa Prock; Mustafa Sahin
Journal:  Mol Ther Methods Clin Dev       Date:  2022-08-29       Impact factor: 5.849

9.  Exon Skipping Through Chimeric Antisense U1 snRNAs to Correct Retinitis Pigmentosa GTPase-Regulator (RPGR) Splice Defect.

Authors:  Giuseppina Covello; Gehan H Ibrahim; Niccolò Bacchi; Simona Casarosa; Michela Alessandra Denti
Journal:  Nucleic Acid Ther       Date:  2022-02-14       Impact factor: 4.244

Review 10.  How to proceed after "negative" exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques.

Authors:  Saskia B Wortmann; Machteld M Oud; Mariëlle Alders; Karlien L M Coene; Saskia N van der Crabben; René G Feichtinger; Alejandro Garanto; Alex Hoischen; Mirjam Langeveld; Dirk Lefeber; Johannes A Mayr; Charlotte W Ockeloen; Holger Prokisch; Richard Rodenburg; Hans R Waterham; Ron A Wevers; Bart P C van de Warrenburg; Michel A A P Willemsen; Nicole I Wolf; Lisenka E L M Vissers; Clara D M van Karnebeek
Journal:  J Inherit Metab Dis       Date:  2022-05-22       Impact factor: 4.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.